Abstract

Arboviruses represent major challenges to public health, particularly in tropical, and subtropical regions, and a substantial risk to other parts of the world as respective vectors extend their habitats. In recent years, two viruses transmitted by Aedes mosquitoes, Chikungunya and Zika virus, have gathered increased interest. After decades of regionally constrained outbreaks, both viruses have recently caused explosive outbreaks on an unprecedented scale, causing immense suffering and massive economic burdens in affected regions. Chikungunya virus causes an acute febrile illness that often transitions into a chronic manifestation characterized by debilitating arthralgia and/or arthritis in a substantial subset of infected individuals. Zika infection frequently presents as a mild influenza-like illness, often subclinical, but can cause severe complications such as congenital malformations in pregnancy and neurological disorders, including Guillain–Barré syndrome. With no specific treatments or vaccines available, vector control remains the most effective measure to manage spread of these diseases. Given that both viruses cause antibody responses that confer long-term, possibly lifelong protection and that such responses are cross-protective against the various circulating genetic lineages, the development of Zika and Chikungunya vaccines represents a promising route for disease control. In this review we provide a brief overview on Zika and Chikungunya viruses, the etiology and epidemiology of the illnesses they cause and the host immune response against them, before summarizing past and current efforts to develop vaccines to alleviate the burden caused by these emerging diseases. The development of the urgently needed vaccines is hampered by several factors including the unpredictable epidemiology, feasibility of rapid clinical trial implementation during outbreaks and regulatory pathways. We will give an overview of the current developments.

Highlights

  • Less than 20 years ago Chikungunya and Zika virus were endemic on the African continent and only caused sporadic and small, local outbreaks [1, 2]

  • Transmission to humans is mediated by the bite of an infected mosquito and the infection can cause a range of clinical outcomes, from asymptomatic to encephalitis (WNV, JFV, and Zika Virus (ZIKV)) or fatal hemorrhagic fever (YFV and Dengue Virus (DENV))

  • During the outbreak on La Reunion in 2006, phylogenetic analysis revealed that the causative virus had acquired a new mutation in the gene coding for E1 that favored infectivity in Aedes albopictus [62]

Read more

Summary

INTRODUCTION

Less than 20 years ago Chikungunya and Zika virus were endemic on the African continent and only caused sporadic and small, local outbreaks [1, 2]. In addition to CHIKV and ZIKV, the family of these viruses comprise different human pathogens that can cause acute infections including Dengue Virus (DENV), Yellow Fever Virus (YFV), West Nile Virus (WNV), Japanese Encephalitis (JEV), Ross River Virus (RRV), and Eastern Equine Encephalitis virus (EEEV). An infamous feature of ZIKV infections is the vertical transmission from mother to child during pregnancy [9, 10] that can lead to abnormal brain development of the fetus [11, 12]. Chikungunya virus (CHIKV) is an alphavirus transmitted by mosquitoes that causes a febrile disease referred to as Chikungunya fever. In addition to the transmission of ZIKV by an animal vector the disease can be transmitted sexually, which increases the risk of disease in emergence in previously non-endemic areas [23]. We will discuss the current regulatory and policy framework that will facilitate and accelerate the development of a ZIKV and a CHIKV vaccine

Molecular Virology and Epidemiology
Pathogenesis and Clinical Manifestations
Animal Models and Immune Responses
Pregnant NHP
Neonate mice
Past and Current Efforts in Vaccine Development
Immunogenicity in mice and NHP
Immunogenicity and efficacy in mice
Findings
AUTHOR CONTRIBUTIONS

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.